Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
14. lappuse
... hydrochloride ) prepara- tions meeting all the following condi- tions : ( i ) The isoamylhydrocupreine and zo- lamine hydrochloride are prepared in dosage form suitable for self - medica- tion as rectal suppositories or as an ointment ...
... hydrochloride ) prepara- tions meeting all the following condi- tions : ( i ) The isoamylhydrocupreine and zo- lamine hydrochloride are prepared in dosage form suitable for self - medica- tion as rectal suppositories or as an ointment ...
15. lappuse
... hydrochloride ( 1- cyclohexylhexahydrobenzoic acid . B - di- ethylaminoethyl ester hydrochloride ; diethylaminocarbethoxy - bicyclohexyl hydrochloride ) preparations meeting all the following conditions : ( i ) The dicyclomine hydrochloride ...
... hydrochloride ( 1- cyclohexylhexahydrobenzoic acid . B - di- ethylaminoethyl ester hydrochloride ; diethylaminocarbethoxy - bicyclohexyl hydrochloride ) preparations meeting all the following conditions : ( i ) The dicyclomine hydrochloride ...
17. lappuse
... hydrochloride ( 4 - N- butoxyphenyl y - morpholinopropyl ether hydrochloride ) preparations meeting all the following conditions : ( 1 ) The pramoxine hydrochloride is prepared , with or without other drugs , in a dosage form suitable ...
... hydrochloride ( 4 - N- butoxyphenyl y - morpholinopropyl ether hydrochloride ) preparations meeting all the following conditions : ( 1 ) The pramoxine hydrochloride is prepared , with or without other drugs , in a dosage form suitable ...
18. lappuse
... hydrochloride ) prepara- tions meeting all the following condi- tions : ( i ) The dyclonine hydrochloride is prepared , with or without other drugs , in a dosage form suitable for use as a cream or ointment in self - medication by ...
... hydrochloride ) prepara- tions meeting all the following condi- tions : ( i ) The dyclonine hydrochloride is prepared , with or without other drugs , in a dosage form suitable for use as a cream or ointment in self - medication by ...
19. lappuse
... hydrochloride ; 1- ( o - methoxyphenyl ) -2 - methylamino- propane hydrochloride ) preparations meeting all the following conditions : ( i ) The methoxyphenamine hydro- chloride is prepared with appropriate amounts of a suitable ...
... hydrochloride ; 1- ( o - methoxyphenyl ) -2 - methylamino- propane hydrochloride ) preparations meeting all the following conditions : ( i ) The methoxyphenamine hydro- chloride is prepared with appropriate amounts of a suitable ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning